Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.
Founded: | 1996 | Country: | Germany |
Employees: | N/A | City: | N/A |
Market Cap: | 14.1B | IPO Year: | 1996 |
Target Price: | $23.00 | AVG Volume (30 days): | 280.3K |
Analyst Decision: | Hold | Number of Analysts: | 1 |
Dividend Yield: | Dividend Payout Frequency: | Annual | |
EPS: | 2.50 | EPS Growth: | 46.47 |
52 Week Low/High: | $17.93 - $24.31 | Next Earning Date: | 02-18-2025 |
Revenue: | $21,457,738,113 | Revenue Growth: | -1.15% |
Revenue Growth (this year): | 0.24% | Revenue Growth (next year): | 3.41% |
FMS Breaking Stock News: Dive into FMS Ticker-Specific Updates for Smart Investing
PR Newswire
a day ago
PR Newswire
4 days ago
Zacks
6 days ago
Zacks
7 days ago
Zacks
7 days ago
Simply Wall St.
15 days ago
Zacks
19 days ago
Zacks
a month ago
The information presented on this page, "FMS Fresenius Medical Care AG - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.